Quantification of 1,3‐β‐ d ‐glucan by Wako β‐glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study

Biomarkers of fungal infection: Expert opinion on the current situations

(2020) Emilio Bouza et al.   Revista Espanola de Quimioterapia

Beta-D-glucan for Diagnosing Pneumocystis Pneumonia: a direct comparison between the Wako β-glucan assay and the Fungitell assay

(2019) Toine Mercier et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

(2019) J Peter Donnelly et al.   CLINICAL INFECTIOUS DISEASES

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Cell surface receptors and associated signaling pathways)

(2018) J. Aguilar-Company et al.   CLINICAL MICROBIOLOGY AND INFECTION

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid or myeloid cells surface antigens [II]: CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4)

(2018) L. Drgona et al.   CLINICAL MICROBIOLOGY AND INFECTION

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents)

(2018) J.W. Baddley et al.   CLINICAL MICROBIOLOGY AND INFECTION

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors)

(2018) K.L. Winthrop et al.   CLINICAL MICROBIOLOGY AND INFECTION

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors)

(2018) M. Reinwald et al.   CLINICAL MICROBIOLOGY AND INFECTION

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors)

(2018) G. Redelman-Sidi et al.   CLINICAL MICROBIOLOGY AND INFECTION

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52)

(2018) M. Mikulska et al.   CLINICAL MICROBIOLOGY AND INFECTION

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

(2018) A.J. Ullmann et al.   CLINICAL MICROBIOLOGY AND INFECTION

Diagnosing Invasive Candidiasis

(2018) Cornelius J. Clancy et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Invasive candidiasis

(2018) Peter G. Pappas et al.   Nature Reviews Disease Primers

Serological biomarkers of candidemia: a retrospective evaluation of three assays

(2018) Karl Dichtl et al.   INFECTION

Comparative Analysis of the Wako β-Glucan Test and the Fungitell Assay for Diagnosis of Candidemia and Pneumocystis jirovecii Pneumonia

(2018) Ricarda Friedrich et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology (AGIHO)

(2018) Markus Ruhnke et al.   MYCOSES

Outcome and potentially modifiable risk factors for candidemia in critically ill burns patients: A matched cohort study

(2018) Emmanuel Dudoignon et al.   MYCOSES

Use of 1,3-β-D-glucan in invasive fungal diseases in hematology patients

(2017) Daniele Roberto Giacobbe et al.   Expert Review of Anti-Infective Therapy

Biomarker-based strategy for early discontinuation of empirical antifungal treatment in critically ill patients: a randomized controlled trial

(2017) Anahita Rouzé et al.   INTENSIVE CARE MEDICINE

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

(2017) Andrew Rhodes et al.   INTENSIVE CARE MEDICINE

Invasive mould infections in the ICU setting: complexities and solutions

(2017) Matteo Bassetti et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection

(2017) John E. Mazuski et al.   Surgical Infections

Candidemia in non-ICU surgical wards: Comparison with medical wards

(2017) Antonio Vena et al.   PLoS One

(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study

(2016) Brunella Posteraro et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Discontinuation of empirical antifungal therapy in ICU patients using 1,3-β-d-glucan

(2016) Marcio Nucci et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

ECIL guidelines for the diagnosis ofPneumocystis jiroveciipneumonia in patients with haematological malignancies and stem cell transplant recipients

(2016) Alexandre Alanio et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Combination ofCandidabiomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment

(2016) M. Carmen Martínez-Jiménez et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Epidemiology and outcomes of patients with invasive mould infections: a retrospective observational study from a single centre (2005-2009)

(2015) Lena Klingspor et al.   MYCOSES

A comprehensive diagnostic approach using galactomannan, targeted β-d-glucan, baseline computerized tomography and biopsy yields a significant burden of invasive fungal disease in at risk haematology patients

(2014) M. Mansour Ceesay et al.   BRITISH JOURNAL OF HAEMATOLOGY

Evaluation of antifungal use in a tertiary care institution: antifungal stewardship urgently needed

(2014) M. Valerio et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Serum (1,3)-beta-D-glucan is an inefficient marker of breakthrough candidemia

(2014) Masahiro Abe et al.   MEDICAL MYCOLOGY

Automation of serum (1->3)-beta-D-glucan testing allows reliable and rapid discrimination of patients with and without candidemia

(2014) F. Pruller et al.   MEDICAL MYCOLOGY

Serum 1,3-beta-d-glucan for antifungal treatment stratification at the intensive care unit and the influence of surgery

(2014) Jürgen Prattes et al.   MYCOSES

β-Glucan Antigenemia Anticipates Diagnosis of Blood Culture–Negative Intraabdominal Candidiasis

(2013) Frederic Tissot et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Finding the “Missing 50%” of Invasive Candidiasis: How Nonculture Diagnostics Will Improve Understanding of Disease Spectrum and Transform Patient Care

(2013) Cornelius J. Clancy et al.   CLINICAL INFECTIOUS DISEASES

An Italian consensus for invasive candidiasis management (ITALIC)

(2013) L. Scudeller et al.   INFECTION

A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill Patients

(2012) Stijn I. Blot et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Clinical utility of fungal screening assays in adults with severe burns

(2012) Dana M. Blyth et al.   BURNS

ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

(2012) O.A. Cornely et al.   CLINICAL MICROBIOLOGY AND INFECTION

ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures

(2012) M. Cuenca-Estrella et al.   CLINICAL MICROBIOLOGY AND INFECTION

β-D-glucan Surveillance with Preemptive Anidulafungin for Invasive Candidiasis in Intensive Care Unit Patients: A Randomized Pilot Study

(2012) Kimberly E. Hanson et al.   PLoS One

Emerging Invasive Fungal Diseases in Transplantation

(2012) Perrine Parize et al.   Current Infectious Disease Reports

 -D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis

(2011) D. E. Karageorgopoulos et al.   CLINICAL INFECTIOUS DISEASES

 -Glucan Antigenemia Assay for the Diagnosis of Invasive Fungal Infections in Patients With Hematological Malignancies: A Systematic Review and Meta-Analysis of Cohort Studies From the Third European Conference on Infections in Leukemia (ECIL-3)

(2011) F. Lamoth et al.   CLINICAL INFECTIOUS DISEASES

Diagnostic Accuracy of Serum 1,3-β-d-Glucan for Pneumocystis jiroveci Pneumonia, Invasive Candidiasis, and Invasive Aspergillosis: Systematic Review and Meta-Analysis

(2011) Akira Onishi et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Clinical viability of Fungitell, a new (1→3)-β-d-glucan measurement kit, for diagnosis of invasive fungal infection, and comparison with other kits available in Japan

(2011) Koichiro Yoshida et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Early serum (1→3)-β-D-glucan levels in patients with burn injury

(2011) Jeffrey W. Shupp et al.   MYCOSES

Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database

(2010) Dimitrios P. Kontoyiannis et al.   CLINICAL INFECTIOUS DISEASES

1,3- -D-Glucan Antigenemia for Early Diagnosis of Invasive Fungal Infections in Neutropenic Patients with Acute Leukemia

(2008) L. Senn et al.   CLINICAL INFECTIOUS DISEASES

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES

Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry

(2008) D. Neofytos et al.   CLINICAL INFECTIOUS DISEASES